Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisone in Advanced Heart Failure and Hyperuricemia
NCT02282683Phase 3Unknown
- Sponsor
- Hebei Medical University
- Start
- Dec 2013
- Primary completion
- Dec 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of prednisone in heart failure (HF) and hyperuricemia, sponsored by Hebei Medical University. Primary endpoint: Mortality within 12 months. Status: unknown.
02
Drugs
prednisone
03
Conditions
heart failure (HF)hyperuricemia
Beyond the preview
Go deeper on NCT02282683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02282683.